19.17
+0.42(+2.24%)
Currency In USD
Address
8 Moore Drive
Durham, NC 27709
United States of America
Phone
(480)-295-7600
Website
Sector
Healthcare
Industry
Biotechnology
Employees
15500
First IPO Date
June 20, 2023
| Name | Title | Pay | Year Born |
| Mr. Thomas H. Pike | Chief Executive Officer & Chairman | 2.19M | 1959 |
| Mr. Mark A. Morais | Chief Operating Officer & President of Clinical Services | 732,472 | 1977 |
| Ms. Jill McConnell | Chief Financial Officer | 735,386 | 1975 |
| Stillman Hanson | General Counsel & Corporate Secretary | 0 | N/A |
| Dr. John J. Doyle M.D. | President of Consulting | 0 | N/A |
| Ms. Hima B. Inguva | Head of Investor Relations & Corporate Development | 0 | N/A |
| Mr. Robert Parks | Chief Accounting Officer | 0 | N/A |
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.